Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-040445
Filing Date
2021-03-24
Accepted
2021-03-23 19:45:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2110678d1_sc13da.htm SC 13D/A 45513
  Complete submission text file 0001104659-21-040445.txt   47064
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Subject) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-58217 | Film No.: 21766135
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address
Leen Ann M. (Filed by) CIK: 0001763026 (see all company filings)

Type: SC 13D/A